Large cell neuroendocrine carcinoma (LCNEC), a rare and aggressive type of lung cancer, has a high chance of metastasis, no standard treatment and a poor survival rate. A study published in Nature Communications provides a new understanding of the disease and uncovers a potential target for treatment.

Amylin, a hormone that controls appetite and blood sugar by activating three different receptors in the brain, could be the basis for the next blockbuster obesity drugs. A University of Oklahoma study published today in the journal Science Signaling reveals a new understanding of how amylin receptors react upon being activated, an advancement that will be crucial to the field of drug development.

The University of Oklahoma College of Dentistry has earned a five-year, $2.1 million grant from the Health Resources and Services Administration (HRSA) to expand the workforce of pediatric dentists in Oklahoma and increase access to comprehensive oral health care.

University of Oklahoma researchers are conducting a first-of-its-kind study to determine whether cannabis use affects recovery from the wounds associated with head and neck cancer surgery. The outcomes may have implications for other types of surgery and conditions.

With roughly one-quarter of the University of Oklahoma’s research rooted in AI, OU is harnessing its transformative power across fields to drive real-world solutions and equip students to thrive as professionals and citizens amid rapid technological change. To expand AI-driven innovation at the university and further a commitment to providing students with a leading AI education, OU has named Shishir Shah, Ph.D., as the first university-wide Chief Artificial Intelligence Officer, pending OU Regents’ approval.